Peter Georgantopoulos

542 total citations
21 papers, 224 citations indexed

About

Peter Georgantopoulos is a scholar working on Oncology, Health and Epidemiology. According to data from OpenAlex, Peter Georgantopoulos has authored 21 papers receiving a total of 224 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Health and 4 papers in Epidemiology. Recurrent topics in Peter Georgantopoulos's work include Polyomavirus and related diseases (5 papers), Global Cancer Incidence and Screening (3 papers) and Influenza Virus Research Studies (2 papers). Peter Georgantopoulos is often cited by papers focused on Polyomavirus and related diseases (5 papers), Global Cancer Incidence and Screening (3 papers) and Influenza Virus Research Studies (2 papers). Peter Georgantopoulos collaborates with scholars based in United States, Finland and Germany. Peter Georgantopoulos's co-authors include Erik R. Dubberke, Charles L. Bennett, Kathlyn Sue Haddock, John F. DiPersio, H. Jean Khoury, Linda M. Mundy, James M. Hollands, LeAnn B. Norris, Kathleen McMullen and David K. Warren and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Peter Georgantopoulos

21 papers receiving 221 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Georgantopoulos United States 8 78 72 47 28 28 21 224
Qianxi Feng United States 8 34 0.4× 36 0.5× 41 0.9× 15 0.5× 9 0.3× 18 262
Julie Asch United States 12 89 1.1× 71 1.0× 42 0.9× 32 1.1× 2 0.1× 24 295
Irfan Vaziri United States 7 89 1.1× 100 1.4× 88 1.9× 10 0.4× 4 0.1× 11 296
Kibum Jeon South Korea 9 86 1.1× 61 0.8× 64 1.4× 30 1.1× 35 301
Lisa Anderson United States 9 64 0.8× 92 1.3× 72 1.5× 18 0.6× 3 0.1× 16 335
Larissa Henze Germany 7 111 1.4× 29 0.4× 107 2.3× 24 0.9× 1 0.0× 19 255
Luisa Verga Italy 10 143 1.8× 103 1.4× 122 2.6× 19 0.7× 1 0.0× 33 288
G.J. Timmers Netherlands 6 48 0.6× 48 0.7× 57 1.2× 13 0.5× 1 0.0× 7 152
Choon Chiat Oh Singapore 11 102 1.3× 113 1.6× 120 2.6× 31 1.1× 4 0.1× 50 433
Michael May United States 12 151 1.9× 98 1.4× 123 2.6× 5 0.2× 12 0.4× 38 502

Countries citing papers authored by Peter Georgantopoulos

Since Specialization
Citations

This map shows the geographic impact of Peter Georgantopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Georgantopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Georgantopoulos more than expected).

Fields of papers citing papers by Peter Georgantopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Georgantopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Georgantopoulos. The network helps show where Peter Georgantopoulos may publish in the future.

Co-authorship network of co-authors of Peter Georgantopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Georgantopoulos. A scholar is included among the top collaborators of Peter Georgantopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Georgantopoulos. Peter Georgantopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, Charles L., Joseph Magagnoli, Krishna Gundabolu, et al.. (2024). A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases. PLoS ONE. 19(9). e0308205–e0308205. 1 indexed citations
2.
Bennett, Charles L., Peter Georgantopoulos, Robert Peter Gale, et al.. (2023). United States’ regulatory approved pharmacotherapies for nuclear reactor explosions and anthrax-associated bioterrorism. Expert Opinion on Drug Safety. 22(9). 783–788. 3 indexed citations
3.
Riekhof, Forest, Yan Yan, Charles L. Bennett, et al.. (2023). Hospitalizations Among Veterans Treated for Metastatic Prostate Cancer With Abiraterone or Enzalutamide. Clinical Genitourinary Cancer. 22(2). 18–26.e3. 6 indexed citations
4.
Georgantopoulos, Peter, Jan M. Eberth, Bo Cai, et al.. (2021). A spatial assessment of prostate cancer mortality-to-incidence ratios among South Carolina veterans: 1999–2015. Annals of Epidemiology. 59. 24–32. 2 indexed citations
5.
Georgantopoulos, Peter, Jan M. Eberth, Bo Cai, et al.. (2020). Patient- and area-level predictors of prostate cancer among South Carolina veterans: a spatial analysis. Cancer Causes & Control. 31(3). 209–220. 6 indexed citations
6.
Georgantopoulos, Peter, Huiying Yang, LeAnn B. Norris, & Charles L. Bennett. (2019). Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors. Cancer Medicine. 8(5). 2233–2240. 8 indexed citations
7.
Georgantopoulos, Peter. (2018). The Importance of Person and Place in Predicting Prostate Cancer Incidence and Mortality among United States Veterans Seeking Veterans Health Administration Care. Scholar Commons (University of South Carolina). 1 indexed citations
8.
Patel, Manali I., Monika Parisi, Corey Pelletier, Charles Bennett, & Peter Georgantopoulos. (2017). P1.06-020 Prevalence of Autoimmune Disease in US Veterans With Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 12(1). S677–S678. 3 indexed citations
9.
Sabol, Rachel A., Virginia Noxon, Oliver Sartor, et al.. (2017). Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR). Cancer Medicine. 6(7). 1541–1551. 21 indexed citations
10.
Yang, Y. Tony, Sumimasa Nagai, Brian Chen, et al.. (2016). Generic oncology drugs: are they all safe?. The Lancet Oncology. 17(11). e493–e501. 27 indexed citations
11.
Norris, LeAnn B., Peter Georgantopoulos, Gowtham Rao, Oliver Sartor, & Charles L. Bennett. (2015). Rituximab is associated with increased risk of Progressive Multifocal Leukoencephalopathy developing among non-HIV-infected Veterans with Chronic Lymphocytic Leukemia.. Journal of Clinical Oncology. 33(15_suppl). e18033–e18033. 3 indexed citations
12.
Merchant, Anwar T., et al.. (2015). Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes. Journal of Dental Research. 95(4). 408–415. 30 indexed citations
13.
14.
Norris, LeAnn B., Peter Georgantopoulos, Gowtham Rao, Kathlyn Sue Haddock, & Charles L. Bennett. (2014). Association between rituximab use and progressive multifocal leukoencephalopathy among non-HIV, non-Hodgkin lymphoma Veteran’s Administration patients.. Journal of Clinical Oncology. 32(15_suppl). e19540–e19540. 5 indexed citations
15.
16.
Georgantopoulos, Peter, et al.. (2010). Community Collaboration in a Community H1N1 Vaccination Program. Journal of Community Health Nursing. 27(3). 121–125. 2 indexed citations
17.
Georgantopoulos, Peter, et al.. (2009). Importance of Routine Public Health Influenza Surveillance: Detection of an Unusual W-Shaped Influenza Morbidity Curve. American Journal of Epidemiology. 170(12). 1533–1540. 4 indexed citations
18.
Dubberke, Erik R., Kathleen McMullen, Jennie Mayfield, et al.. (2009). Hospital-Associated Clostridium difficile Infection: Is It Necessary to Track Community-Onset Disease?. Infection Control and Hospital Epidemiology. 30(4). 332–337. 19 indexed citations
19.
Litvin, Marina, Kimberly A. Reske, Jennie Mayfield, et al.. (2009). Identification of a Pseudo-Outbreak ofClostridium difficileInfection (CDI) and the Effect of Repeated Testing, Sensitivity, and Specificity on Perceived Prevalence of CDI. Infection Control and Hospital Epidemiology. 30(12). 1166–1171. 26 indexed citations
20.
Dubberke, Erik R., James M. Hollands, Peter Georgantopoulos, et al.. (2006). Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?. Bone Marrow Transplantation. 38(12). 813–819. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianxi Feng Breakdown of academic impact, for papers by Julie Asch Breakdown of academic impact, for papers by Irfan Vaziri Breakdown of academic impact, for papers by Kibum Jeon Breakdown of academic impact, for papers by Lisa Anderson Breakdown of academic impact, for papers by Larissa Henze Breakdown of academic impact, for papers by Luisa Verga Breakdown of academic impact, for papers by G.J. Timmers Breakdown of academic impact, for papers by Choon Chiat Oh Breakdown of academic impact, for papers by Michael May
Rankless by CCL
2026